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Objectives . The present study Investigated the presence of
anlimyosin autoantibodies in sera of patients with myocarditis and
in three control groups: healthy blood donors, patients with
alcoholic cardiomyopathy and patients with other cardiac dis-
eases .
Background. An increasing body of evidence indicates that in
the course of myocarditis, autoimmunologic mechanisms may play
a pathogenetic role. Animal studies with Coxsackie 113 virus-
induced murine myocarditis could demonstrate the appearance of
circulating autoantibedies against cardiac myosin .
Methods . Sera were analyzed by enzyme-linked immunosor-
bent assay (ELISA) and Western blot with human left ventricular
myosin as antigen .
Results. Seventeen (42%) of 40 serum samples from patients
with myocarditis showed antibody-binding against myosin,
whereas only 1 (2.5%) of 39 samples from healthy blood donors
and 9 (21%) of 43 samples from patients with other cardiac
Currently, most clinical cases of myocarditis in humans are
suspected to be of viral origin (1,2) . Viral ribonucleic acid
(RNA) has been detected in a certain percent of patients with
myocarditis and dilated cardiomyopathy (3) . Although the
pathogenetic mechanisms are only vaguely understood, an
increasing body of evidence indicates that in the course of
myocarditis, autoimmunologic mechanisms may play a
pathogenetic role. Autoimmunity initiated by the viral infec-
tion may aggravate and perpetuate myocarditis and perhaps
result in dilated cardiomyopathy .
In humans, several autoantigens have been identified,
including the adenosine nucleotide translocator (ANT), the
calcium chani el, the Connexon and the beta-adrenoceptor
(4-8) . In experimental studies (5,6), it was shown that the
autoantibodies against adenosine nucleotide translocator in-
fluence the function of the carrier protein in vitro and impair
cardiac function in vivo. This suggests a pathogenetic role of
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diseases showed autoantibodies against myosin (p < 0 .05 vs.
myocarditis) . In sera from patients with alcoholic cardiomyopathy
(a = 12), no antibodies against human ventricular myosin could
be detected. In Western blots, the aulimyosin antibodies in
patients with myocarditis bound to the myosin heavy chain . Using
protein-A sepharose chromatography, it could be shown that the
antimyosin autoantibodies are of the immunoglobulin G (IgG)
type. In ELISA, the antimyosin autoantibodies bind equally to
myosin prepared from either cardiac or skeletal muscle, respec-
tively.
Conclusions. These results demonstrate the presence of au-
toantibodies against human ventricular myosin in patients with
myocarditis . The prevalence of these autoantibodies is signifi-
cantly higher in patients with myocarditis than in patients with
other cardiac diseases. No organ specificity of the autoantibodies
could be detected .
(J Am Coll Cardiol 1994;23:146-53)
these autoantibodies in the course of myocarditis and dilated
cardiomyopathy .
Animal studies (9) with Coxsackie B3 virus--induced
murine myocarditis demonstrated the appearance of circu-
lating autoantibodies against cardiac tissue . In Western blot
analysis, these antibodies react with the heavy chain of
cardiac myosin (10,11). Immunization of the animals with
cardiac myosin also leads to alterations resembling virus-
induced myocarditis (12) .
In the present study, we show that autoantibodies against
human ventricular myosin can be detected in patients with
myocarditis .
Methods
Study group . Serum samples from 40 patients with acute
or chronic myocarditis and 94 control subjects-12 with
alcoholic cardiomyopathy, 43 patients with other cardiac
diseases and 39 healthy control subjects-were studied .
Blood samples for immunologic studies were taken at the
time of routine laboratory tests . Patients were examined
with invasive and noninvasive techniques, including physi-
cal examination, routine laboratory tests, rest and exercise
electrocardiography, echocardiography, right and left heart
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catheterization, coronary angiography, left ventriculography
and right heart myocardial biopsy .
All patients were considered to have possible myocarditis
on the basis of history and clinical presentation . Endomyo-
cardial biopsy specimens were examined histologically ac-
cording to the Dallas criteria (13) and immunohistologically
(14,15) . At least seven biopsy specimens from each patient
were analyzed . Histologic sections were analyzed by light
microscopy for evidence of myocardial necrosis, interstitial
fibrosis and the presence of lymphocytic infiltrates . Because
evaluation of myocardial biopsy specimens by light micros-
copy alone is difficult (16,17) and has a high rate of interob-
server variability (18) and sampling error(19), this technique
is thought to be rather insensitive in the diagnosis of myo-
carditis (20). We therefore also examined the biopsy speci-
mens from our patients by immunohistologic techniques
developed with various monoclonal antibodies . Antibodies
directed against surface antigens of human lymphocytes
(CD3, CD4, CD8) were used to detect and quantitate lym-
phocytic infiltrates in myocardial tissue (14,15,21-23) . Addi-
tionally, with antibodies against the major histocornpatibiiity
antigens (MHC) . an increased expression of MHC I and 11
antigens could be detected . With these techniques, the
diagnostic accuracy in the biopsy specimens could be in-
creased (24) and the interobserver variability minimized
(14,15) .
Acute myocarditis was diagnosed when histologic sec-
tions from endomyocardial biopsy specimens revealed lym-
phocytic infiltrates in the region of myocardial necrosis .
When lymphocytic infiltrates were seen by light microscopy
in histologic sections without myocyte necrosis, the biopsy
was repeated after 3 months . Ongoing myocarditis was
diagnosed when the lymphocytic infiltrates had persisted or
were increased at the second biopsy . When the lymphocytic
infiltrates had disappeared, the patients were not classified
as having myocarditis . When the immunohistologic exami-
nation revealed lymphocytic infiltrates and increased expres-
sion of MHC I and II antigens, the biopsy was also repeated
after 3 months . When the lymphocytic infiltrates and in-
creased expression of MHC I and It antigens persisted in
two consecutive biopsies, a chronic inflammatory process of
the myocardium was assumed . These patients were classi-
fied as having chronic myocarditis .
A total of 198 consecutive patients with clinically sus-
pected myocarditis were analyzed according to these crite-
ria. On the basis of the Dallas criteria (13), which were meant
to provide "a simple reproducible working classification"
(17) rather than a definitive classification of acute myocardi-
tis or a "conditio sine qua non" for the diagnosis of
myocarditis (17), three of our patients met the criteria for
acute myocarditis and five other patients for ongoing myo-
carditis. In 32 patients . the diagnosis of chronic myocarditis
was made on the basis of immunohistologic data . The
clinical data from these 40 patients are given in Table 1 .
Patients were excluded if they had coronary heart disease
at selective coronary angiography, systemic blood pressure
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'fable 1
. Clinical Findings in 40 Patients With Myocarditis
P~,~i831i0n
Fatigue
Pericardial effusion
New rhythm disturbances
Electrocardiographic changes
Elevated creatine kinase level
Left ventricular dysfunction
Patients
(no.p
>150190 mm Hg, concomitant systemic or endocrinologic
diseases known to cause left ventricular dysfunction or
excessive alcohol consumption .
Three groups of control subjects were enrolled in this
study. Control group I comprised 43 patients with various
cardiac diseases, including 31 patients with coronary artery
disease, 7 with valvular heart disease and 5 with hyperten-
sive heart disease . Control group lI comprised 12 patients
with alcoholic cardiomyopathy . These patients presented
with impaired left ventricular function and had a history of
excessive alcohol consumption (>I g of alcohoUkg body
weight per day) . Clinical and laboratory findings as well as
the histologic examination revealed no cause of impaired left
ventricular function other than excessive alcohol consump-
tion . Control group III consisted of 39 healthy persons with
no history of myocardial disease .
All subjects provided informed consent before participat-
ing in the study. The study protocol was approved by the
ethics committee of the University of Dilsseldorf.
Preparation of myosin. Myosin was prepared according
to the method of Offer et al . (25), with slight modifications
according to the method of L,ompre et al . (26) . Briefly,
cardiac muscle specimens were obtained from the patho-
logic institute within 24 h after death . After homogeni-
zation, myosin was extracted in modified Guba-Straub
solution (potassium chloride 0.3 mol/liter, magnesium chlo-
ride I mmollliter, sodium phosphate 150 mmollliter, sodium
pyrophosphate 10 mmollliter, ethylenediaminetetraacetic
acid (EDTA) 10 mmollliter, beta-mercaptoethanol 1%, pH
6.5), centrifuged and then precipitated by lowering the ionic
strength with EDTA I mmollliter, beta-mercaptoethanol 1%,
pH 6.5. After dissociating actin with sodium pyrophosphate
100 mmollliter, adenosine 5'-triphosphate (ATP) 6 mmol/liter
in EDTA 4 mmollliter, dithiothreitol 3 mmol/liter, pH 7 .0,
further purification was carried out by ammonium sulfate
fractionation . For immunization procedures, the myosin was
further purified by ion exchange chromatography on DEAE
Sephadex, using a potassium gradient from 0 to 500 mmol/
liter. The myosin solution was then dialyzed overnight
against sodium chloride 500 mmollliter, tris(hydroxymethyl)-
aminomethane (Tris)/hydrochloride 10 mmollliter, EDTA
I mmol/liter, pH 6.5 at 4°C and stored in this solution
. The
purity was routinely checked by sodium dodecylsulfate gel
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electrophoresis. Skeletal muscle myosin was prepared using
the same protocol from human iliopsoas muscle .
Preparation of antihuman ventricular myosin antibodies .
Antibodies against human ventricular myosin were raised in
rabbits as described by Schwartz et al . (27) . One week
before immunization, blood was taken from the rabbits as
preimmune serum. Rabbits received an injection of the
purified protein in Freund's incomplete adjuvant every 2
weeks for 2 months. Blood was drawn before each immuni-
zation procedure from the auricular artery for antibody titer
monitoring . Antibody titers were maximal after five injec-
tions.
The immunoglobulin G (IgG) fractions of human sera and
rabbit antisera were prepared on a protein-A sepharose
column (28). Protein-A sepharose was equilibrated with
phosphate-buffered saline solution with 0 .05% azide in an
appropriate column. A total of 2 ml of serum was run on the
column and the fraction of unbound protein was collected
("wash fraction"). The IgG bound to the column was eluted
with 0.1 mol/liter citrate, 0 .5 moUliter sodium chloride, pH
2.9 immediately neutralized with 2 mol/liter Tris to a final pH
of 7.4, then dialyzed against phosphate-buffered saline solu-
tion overnight and concentrated by ultrafiltration .
Enzyme-linked immunosorbent assay (ELISA). The
ELISA technique was performed as previously described by
Lem and Hales (29) . Briefly, I Aglwell of purified myosin in
phosphate-buffered saline solution was air dried on polyvinyl
chloride 96 well plates . Free binding sites were blocked by
incubating the plates with ELISA diluent (0 .2% Tween, 2%
bovine serum albumin, 0 .4 mmol/liter Thimerosal, in phos-
phate-buffered saline solution) for I h, then antisera or
patient sera diluted in ELISA diluent were added . After
incubation at room temperature for 90 min, plates were
washed three times in phosphate-buffered saline solution and
0.2% Tween, and affinity-purified peroxidase-labeled goat
antirabbit or antihuman antibody was added, respectively .
After 90 min of incubation, the plates were rewashed three
times and substrate (0 .4 mg/ml o-phenylenediamine, 0 .01%
hydrogen peroxide in citrate buffer, pH 5 .0) was added . The
reaction was stopped after 30 min with 4N sulfuric acid and
the samples were read at 492 nm in an automated ELISA
scanner .
To test the specificity of the antibody binding in ELISA,
10 µl of serum in 400µl of phosphate-buffered saline solution
was preincubated with 100 Ag of purified myosin from
different human muscles (human left ventricle, human ilio-
psoas, human sartorius) overnight at 25°C before the ELISA
procedure. Sera were also tested against myosin prepared
from the different muscles . All sera were tested in duplicate .
Western blot analysis. Western blot analysis was carried
out as described previously. Purified myosin was loaded on
a 8% acrylamide gel with a 4 .5% stacking gel (30) . After
migration for 1 h at 125 V and 4 h at 250 V with weight
markers as standard, the proteins were transferred to nitro-
cellulose sheets (31) with 195 mA for 2 h in 70% methanol in
Tris/glycine buffer, pH 8 .3. Appropriate stripes were cut out,
free binding sites blocked with phosphate-buffered saline
solution, 2% bovine serum albumin overnight . The stripes
were then incubated with the first antibody (rabbit antimyo-
sin antisera or patikof sera. respectively) in phosphate-
buffered saline wbnioA, d .2% Tween. After washing three
times with phosphate-hv,&red saline solution, 0.2% Tween,
the second antibody was added (peroxidase-labeled antirab-
bit IgG or antihuman IgO, respectively). The coloration was
carried out in the dark with 0 .5% 4-chloro-naphthol, 0.1%
hydrogen peroxide in methanol 15% in phosphate-buffered
saline solution for 30 min . The specificity of the antibody
binding to myosin was tested by preincubating 30 Al of
serum in 3 ml of phosphate-buffered saline solution, Tween
with 300 pg of myosin prepared from different muscles
overnight at 25°C before incubation with the nitrocellulose
sheets .
Statistical analysis. The threshold for the detection of
antimyosin autoantibodies in sera during ELISA was defined
as the mean value ± 2 SD of the sera from 39 apparently
healthy persons (control group 111) . The two-tailed chi-
square test for independent populations was used to com-
pare the prevalence of antimyosin antibodies in the different
study groups . Statistical significance was defined as p <
0.05 .
Results
Autoantibodies against human ventricular myosin in sera
from patients with myocarditis, alcoholic cardiomyopathy and
other cardiac diseases. To study whether sera from patients
with myocarditis contained anticardiac myosin autoantibod-
ies, the sera were tested by ELISA with human ventricular
myosin as antigen . Control values were established with sera
from 39 apparently healthy persons (control group 111) . Sera
were assumed positive for antimyosin antibodies if the
binding in ELISA was above the mean value ± SD of the
control group III .
Figure f shows the extinction in ELISA of the sera from
patients with myocarditis, alcoholic cardiomyopathy, other
cardiac diseases and healthy blood donors . Table 2 gives the
percent of antimyosin antibody-positive patients in the
various groups . In 17 (42%) of 40 serum samples from
patients with myocarditis, antibodies against human ventric-
ular myosin were detected (p < 0 .05 vs. control group 111) .
One of the 3 patients with acute myocarditis, 2 of the 5
patients with ongoing myocarditis and 14 of the 32 patients
with immunohistologically diagnosed chronic myocarditis
had antimyosin autoantibodies . There was no statistically
significant difference in hemodynamic variables (cardiac
index, ejection fraction, left ventricular end-diastolic pres-
sure) between patients with myocarditis who had antimyosin
antibody-positive versus antimyosin antibody-negative
findings (data not shown) . None of the 12 patients with
alcoholic cardiomyopathy showed antimyosin autoantibod-
ies. In patients with other cardiac diseases, only 9 (21%) of
43 serum samples contained antibodies against human ven-
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Figure 1 . Extinction in ELISA of the sera from patients with
myocarditis (MC), other cardiac diseases (control (Col group 1),
alcoholic cardiomyopathy (control group 11) and healthy blood
donors (control group 111) with human ventricular myosin as antigen
(serum dilution 1 :40) . The black line indicates the mean value ± 2
SD for healthy persons (control group 111) as the threshold for the
detection of antimyosin autoantibodies .
tricular myosin (p < 0.05 vs. patients with myoca, difis, p <
0.05 vs. control group III) . These data demonstrate that
many serum samples from patients with myocarditis contain
autoantibodies against human cardiac ventricular myosin .
The prevalence of antibodies against myosin is significantly
higher in patients with myocarditis than in patients with
other cardiac diseases .
Table 2 shows the prevalence of antimyosin autoantibod-
ies in sera from patients with myocarditis and from the
control patients at different serum dilutions . Nine (22 .5%) of
the 40 patients with myocarditis showed antimyosin antibod-
ies at a serum dilution of 1 :160, 4 (10%) at a dilution of 1 :640,
3 (15%) at 1 :2,560 and 1 (2 .5%) at 1 :10,240 . In the patients
with other cardiac diseases, in only 3 (7%) of 43 could
antimyosin antibodies be detected at a dilution of 1 :160 (p <
0.05 vs. myocarditis) ; at serum dilutions of 1 :640, 1 :2,560
and 1 :10,240, no antibodies were demonstrated in these
patients. To test the specificity of the antibody binding in
ELISA for human ventricular myosin, the sera that showed
antibody binding in ELISA were preincubated with human
Table 2 . Prevalence of Antimyosin Autoantibody-Positive Sera in
Patients With Myocarditis and Control Groups
*p < 0 .05 versus control (Co) groups I (other cardiac diseases), It
(alcoholic cardiomyopathy) and III (healthy blood donors) . tp < 0 .05 versus
myocarditis and control groups II and Ill .
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Figure 2 . Specificity of the antibody binding for human ventricular
myosin. Enzyme-linked immunosorbent assay (ELISA) was per-
formed with serum from patients with myocarditis before and after
preincubation of the serum with human ventricular myosin (see
Melhnrls) . The black line indicates the mean value ± 2 SD for
healthy persons (control group 111) as the threshold for the detection
of antimyosin autoantibodies .
ventricular myosin before the ELISA procedure (Fig . 2). It
was shown that preincubation of the sera with human
ventricular myosin completely prevented the binding of the
sera to human ventricular myosin. This showed that the
binding in ELISA was specific for human ventricular myo-
sin .
Localization of the antigenic determinant on the myosin
molecule. The myosin molecule consists of six polypeptide
chains, two heavy chains of 200 kD (MHQ and four lighter
polypeptides (two of 27 kD [MLCII and two of 10 M
JMLC21) . To study which myosin subunit the antimyosin
autoantibodies are directed against, the sera were tested
against human ventricular myosin in Western blots . Poly-
clonal antibodies against human ventricular myosin raised in
rabbits served as positive control sera . The polyclonal rabbit
antihuman myosin antibodies bound against the myosin
heavy chain (200 M) and against the myosin light chains
(migrating together in the 8% acrylamide gel) (Fig . 3) . Sera
from patients with myocarditis that showed positive anti-
body binding in ELISA bound against the 200-kD protein,
which is the myosin heavy chain. Control sera showed no
antibody binding in Western blots .
After preincubation of the sera with human ventricular
myosin the autoantibody binding to the 200-0 protein was
inhibited . In the region of the myosin light chains (27,000 D,
20,000 D), no autoantibody binding could be detected in the
patient sera
Classification of the autoantibodies against myosin . To
classify the immunoglobulin type of the autoantibodies
against myosin, IgG fractions from the 16 antibody-
containing human sera were prepared on a protein-A
sepharose column
. The various elution fractions were tested
for binding to human ventricular myosin in ELISA. As
shown for one serum sample in Figure 4, the IgG fraction
bound strongly to myosin, whereas the wash fraction con-
Serum
Dilution 1 :40 1 :160 1 :640 1 :2,560 1 :10 .240
Myocarditis 17*
9*
4 3 1
(n = 40) (42%) (22 .5%) (l07c) (7 .5%) (2 .5--/,)
Co I 9r 3 0 0 0
(n = 43) (21%) (7.0%) (2 .3%) (0%) (0%)
Co 11 0 0 0 0 0
(n = 12) (0%) (0%) (0%) (0%) (VC)
CO III 1 0 0 0 0
(n = 39) (2 .5%) (0%) (0%) (0%) (0%)
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Figure 3. Western blot analysis of antimyosin antibodies . Human
ventricular myosin was subjected to polyacrylamide gel electro-
phoresis, transferred to nitrocellulose sheets and incubated with
different sera (see Methods) . Column 1, Rabbit serum with poly-
clonal antibodies against human ventricular myosin . Column 2,
Human serum containing antimyosin autoantibodies . Column 3,
Immunoglobulin 0 fraction prepared from human serum containing
antimyosin autoantibodies . Column 4, Human control serum Ino
antibody binding in enzyme-linked immunosorbent assay IELISAI) .
Column 3, Immunoglobulin G fraction prepared from human control
serum (no antibody binding in ELISA) . Column 6,
Molecular weight
(MW) standard after polyacrylamide gel electrophoresis (Coomassie
BB coloration) . MHC = myosin heavy chain ; MLC = myosin light
chain .
taining other serum proteins, including other immunoglobu-
lins, did not bind to myosin . This demonstrated that the
autoantibodies against human ventricular myosin in patients
with myocarditis are of the IgG type .
Figure 4. Antibody binding in enzyme-linked immunosorbent assay
(ELISA) of serum, immunoglobulin G (lgG) fraction of serum and
"wash fraction ." A representative example from one patient with
myocarditis is shown .
The black line indicates the mean value ±
2 SD for healthy persons (control group 111) as the threshold for the
detection of antimyosin autoantibodies . IgG fraction = ELISA was
performed with the IgG fraction of the serum (see Methods) . Serum
= ELISA was performed with serum from a patient with myocar-
ditis ; "wash" fraction = ELISA was performed with the fraction of
the serum that was not bound to a protein-A sepharose column (see
Methods) .
Extinction
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Figure 5 . Specificity of the antimyosin autoantibodies fur myosin
from different striated muscles . A. Sera were preincubated with
human ventricular myosin (cardiac myosin) or myosin from human
skeletal muscle (skeletal myosin), respectively (see Methods) . B,
Antibody binding in enzyme-linked immunosorbent assay (ELISA)
with myosin from different striated muscles as antigen . The black
line indicates the mean value ± 2 SD for healthy persons (control
group 111) as the threshold for the detection of antimyosin autoanti-
bodies. Cardiac myosin = myosin prepared from human left ventri-
cle (see Methods) . Skeletal myosin = myosin prepared from human
skeletal muscle (see Methods) .
Specificity of the antimyosin antibodies for cardiac ventric-
ular myosin. To examine whether the antimyosin autoanti-
bodies found in sera from patients with myocarditis are
directed specifically against human ventricular myosin, an-
tibody-positive sera were preincubated with myosin pre-
pared from different striated muscles (human left ventricle,
human skeletal muscle) . Figure 5A shows the results for
seven serum samples . Preincubating the samples with any of
the different myosin preparations inhibited autoantibody
binding against human ventricular myosin in ELISA . Using
either myosin from skeletal or cardiac muscle as antigen in
ELISA showed that the sera bound equally to human
ventricular myosin and skeletal myosin (Fig . 5B). This
indicated that there is apparently no organ specificity of the
antimyosin autobodies for human ventricular myosin .
Discussion
Autoantibodies in Imyocarditis . In patients with myocar-
ditis, several studies have demonstrated autoantibodies
JACC Vol . 23, No . I
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against cardiac proteins . Immunofluorescence studies (32-
36) showed autoantibodies against different cardiac struc-
tures (namely, membranes, mitochondria, cytoplasmic anti-
gens). Further studies identified the adenine nucleotide
translocator of the inner mitochondrial membrane (4,37,38),
calcium channel (7), Connexon (33) and cardiac beta-
adrenoreceptor (8) as autoantigens in myocarditis and di-
lated cardiomyopathy . For the adenine nucleotide translo-
cator, a possible functional significance was shown (5,6) .
The hypothesis that autoantibodies against myosin may play
an important role in the pathogenesis of myocarditis is
derived from animal studies . In animal models, antibodies
against cardiac myosin have been demonstrated . Infection
with Coxsackie-B3 virus leads to the development of myo-
carditis in genetically defined mice (39) . In the course of
Coxsackie-B3 virus-induced murine myocarditis, heart-
specific autoantibodies have been demonstrated (li) . In
Western blot analysis, these antibodies bind to a 200-kD
band that is thought to be the myosin heavy chain (10) .
Immunization with myosin leads to histologic and immune-
histologic alterations in mice hearts similar to those with
Coxsackie-B3 virus infection (12). From experimental data
(40), a possible pathogenetic role of the antibodies was
suspected. The present study clearly shows the existence of
autoantibodies against human ventricular myosin in patients
with myocarditis . These autoantibodies are directed against
the myosin heavy chain . No antibody binding was seen with
the myosin light chains . Recently, antibodies against myosin
heavy chains were demonstrated in patients with the clinical
presentation of dilated cardiomyopathy (41) . which in many
cases is thought to be a sequela of myocarditis . In this study,
the sensitive immunohistologic techniques for detecting lym-
phocytic infiltrates in myocardial biopsy specimens were not
applied .
Histologic and immunologic methods for the diagnosis of
myocarditis . In the present study, the diagnosis of myccar-
ditis was made using histologic (Dallas criteria [131) and
mmunohistologic methods . The Dallas classification for the
diagnosis of acute myocarditis was initially established by a
group of outstanding pathologists . The goals of the group
were to: 1) produce a morphologic definition of myocarditis,
2) develop histologic criteria for the diagnosis of myocardi-
tis, 3) establish a simple reproducible working classification,
4) outline the problems and pitfalls in establishing the
diagnosis of myocarditis, 5) assess the applicability and
reproducibility of the classification system itself, and
6) make this information available to other pathologists and
clinicians (13,17) . However, as these pathologists (17) have
emphasized, the Dallas criteria were not meant to establish a
definitive diagnosis of myocarditis and should not be mis-
understood and misinterpreted as a "conditio sine qua non"
of the diagnosis of myocarditis .
The present study used the Dallas criteria (13) in addition
to immunohistologic techniques for the detection of lympho-
cytic infiltrates (14,15,18-20) and an increased expression of
MHC I and 11 antigens . With these techniques, the diagnos-
tic accuracy was increased (24) and the interobserver vari-
ability was minimized (14,15) . We believe that the fact that in
two consecutive biopsy specimens, chronic lymphocytic
infiltrates and an increased expression of MHC I and II
antigens could be detected points to a chronic inflammatory
process in the myocardium and therefore these patients were
classified as having chronic myocarditis . In the present
study, 3 patients met the histologic Dallas criteria for acute
myocarditis and 5 for ongoing myocarditis ; 32 patients met
the immunohistologic criteria for chronic myocarditis . In I
patient with acute myocarditis, 2 patients with ongoing
myocarditis and 14 patients with chronic myocarditis, an-
timyosin antibodies could be detected . Because of the small
number of patients with acute myocarditis and ongoing
myocarditis, a comparison between these groups and the
chronic myocarditis group is not appropriate .
Acute myocarditis can resolve spontaneously, or it may
lead to a chronic inflammatory, perhaps autoimmunologi-
cally mediated, process . In the present study, only one of
three patients with acute myocarditis showed antimyosin
autoantibodies . Because the acute phase of the disease is of
short duration, one cannot expect that IgG autoantibodies
against an intracellular protein as a possible marker of an
autoimmune process are always detectable at this early stage
of the disease . Therefore, it is not surprising that only one of
the three patients with acute myocarditis showed autoanti-
bodies against human ventricular myosin .
In the present study, we found no significant difference in
hemodynamic variables between patients with myocarditis
who had antimyosin antibody positive versus negative find-
ings. At least in some patients, myocarditis is thought to be
a chronic process. In the present study, the hemodynamic
variables were evaluated at only one time point in this
chronic process . Longitudinal studies are necessary to eval-
uate the relation between changes in hemodynamic variables
and the persistence of antimyosin autoantibodies in patients
with myocarditis .
Antimyosin Ruto2atibodles in human cardiac disease . Pa-
tients with impaired ventricular function due to alcoholic
cardiornyopathy did not show autoantibodies against human
ventricular myosin. This is a strong indicator that the pres-
ence of antimyosin autoantibodies is linked to a chronic
inflammatory, perhaps autoirnmunotogically mediated, pro-
cess rather than to the disturbed left ventricular function
itself. In the present study, patients with other cardiac
diseases also showed autoantibodies against human ventric-
ular myosin but to a significantly lower extent
. The preva-
lence of antimyosin autoantibodies in patients with other
cardiac diseases is similar to that in patients 1 year after
cardiac surgery (42) . In the study of Caforio et al . (41), only
1 of 12 serum samples from patients with heart failure due to
other cardiac diseases showed antimyosin antibodies . Their
control group comprised preselected patients with no anti-
body binding to heart tissue in immunofluorescence studies
(41). High antimyosin autoantibody titers were more com-
mon i
n patients with myocarditis than in those with other
JACC Vol. 23, No . I
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cardiac diseases
. This might be interpreted as indirect evi-
dence for an autoimmunologic process in patients with
myocarditis . The present study could not demonstrate any
organ specificity of the antimyosin autoantibodies in patients
with myocarditis . In ELISA, the antibodies bind equally to
ventricular and skeletal myosin, and the binding was equally
inhibited by myosin from ventricular or skeletal muscle . This
is not surprising because the beta-myosin heavy chain of
human cardiac muscle and the myosin heavy chain of slow
skeletal muscle are products of the same gene
(43), and the
ventricular myosin heavy chain in humans is composed of
90% to 95% of beta-myosin heavy chain and only 5% to 10%
of alpha-myosin heavy chain (44) . In mice, immunofluores-
cence studies (10) with cardiac specific antimyosin antibod-
ies demonstrated a striational pattern (10) . In humans,
antibodies showing a striational pattern in immunofluores-
cence were not organ specific and were bound equally to
cardiac and skeletal muscle (45) . Because the autoantibodies
demonstrated in the present study are directed against the
myosin heavy chain, no specificity of the autoantibodies for
either cardiac or skeletal myosin could be expected .
Possible mechanisms of autolmmunity in myocarditis . The
present study provides further evidence of an autoimmuno-
logic process in human myocarditis (40) . The induction of
autoantibodies in the course of myocarditis and dilated
cardiomyopathy is not yet clear . One possible explanation
would be "molecular mimicry ." Schwimmbeck et al . (46),
using computer analysis of protein sequences, identified
regions of high homology between Coxsackie B3 virus and
rabbit cardiac myosin (46) . Using synthetic peptides identi-
cal to those in these regions, an immunologic cross-
reactivity between Coxsackie B3 virus peptides and myosin
peptides was demonstrated (46) . In contrast, the antimyosin
autoantibodies produced in Coxsackie B3 virus-induced
myocarditis in AJJ mice did not cross-react with the virus
(47). This argues against molecular mimicry as the pathoLe-
netic pathway of autoimmunity in inflammatory heart dis-
ease . Another possibility is the exposition of sequestered
antigens to the immune system in the course of myocarditis .
Intracellular proteins such as myosin are possibly exposed to
the immunogenic cells, thus perpetuating the autoimmuno-
logic process .
The pathogenetic mechanisms by which autoantibodies
directed against intracellular proteins such as myosin may
play a role in the autoimmunologic process remain contro-
versial . It cannot be excluded that the antibodies may
penetrate into the myocardial cells and impair cardiac func-
tion (5,6) . Conversely, assessment of whether the detection
of autoantibodies against human ventricular myosin may
serve as an index for the activity of the inflammatory process
in the heart and be useful for monitoring the clinical course
of the disease will require further study . In murine autoim-
mune myocarditis, the antimyosin autoantibodies do not
seem to be involved in the induction of myocarditis (48) . In
this context, it should be noted that scintigraphic studies (49)
with antimyosin antibodies suggest a lysis of heart cells in
patients with myocarditis and dilated cardio*nyopathy .
Conclusions. The present study demonstrates the pres-
ence of autoantibodies against human ventricular myosin in
patients with myocarditis . The prevalence of antimyosin
autoantibodies is significantly higher in patients with myo-
carditis than in patients with other cardiac diseases . The
antimyosin autoantibodies are of the IgG type . They are
directed against the myosin heavy chain and react with
myosin from cardiac and skeletal muscles .
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